Processa Pharmaceuticals clinical trials we track

Check company identity source

Phase 2 3 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change in Gastric Emptying Rate From Baseline as Determined by the Area Under the Curve (AUC) of the Gastric Emptying Rate Description: Change from baseline in gastric emptying rate was determined by the AUC by Gastric Emptying Breath Test (GEBT) at Day 28 after administration of PCS12852 or placebo. Time frame: ~28 days Measure: Change in Gastric Emptying Rate From Baseline Using t50 Metric for Gastric Emptying Rate Description: Time for 50% gastric emptying (t50) metric assessed by the GEBT Time frame: ~28 days Measure: Concentrations of PCS12852 in Plasma - Cmax Description: PK parameters were estimated from concentration-time data using noncompartmental methods, as data permitted. Time frame: Day 1 Measure: Concentrations of PCS12852 in Plasma - AUC0-last Description: PK parameters were estimated from concentration-time data using noncompartmental methods, as data permitted. Time frame: Day 1 Measure: Concentrations of PCS12852 in Plasma - AUC0-last Description: PK parameters were estimated from concentration-time data using noncompartmental methods, as data permitted. Time frame: Day 28 Measure: Concentrations of PCS12852 in Plasma - Cmax Description: PK parameters were estimated from concentration-time data using noncompartmental methods, as data permitted. Time frame: Day 28. After: Measure: Change in Gastric Emptying Rate From Baseline as Determined by the Area Under the Curve (AUC) of the Gastric Emptying Rate Description: Change from baseline in gastric emptying rate was determined by the AUC by Gastric Emptying Breath Test (GEBT) at Day 28 after administration of PCS12852 or placebo. Time frame: ~28 days Measure: Change in Gastric Emptying Rate From Baseline Description: Time for 50% gastric emptying (t50) metric assessed by the GEBT Time frame: ~28 days Measure: Concentrations of PCS12852 in Plasma - Cmax Description: PK parameters were estimated from concentration-time data using noncompartmental methods, as data permitted. Time frame: Day 1 Measure: Concentrations of PCS12852 in Plasma - AUC0-last Description: PK parameters were estimated from concentration-time data using noncompartmental methods, as data permitted. Time frame: Day 1 Measure: Concentrations of PCS12852 in Plasma - AUC0-last Description: PK parameters were estimated from concentration-time data using noncompartmental methods, as data permitted. Time frame: Day 28 Measure: Concentrations of PCS12852 in Plasma - Cmax Description: PK parameters were estimated from concentration-time data using noncompartmental methods, as data permitted. Time frame: Day 28.

Check registry source

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 90 participants (planned). After: 20 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Sep 2026. After: 29 Jul 2026.

Recruitment status changed

Before: Recruiting. After: Terminated.

Check registry source